浙商证券：手术机器人行业高增长可期 出海有望形成持续新增长拉动

Core Insights - The surgical robot market is expected to grow significantly, with a projected market size exceeding 70 billion RMB and a CAGR of approximately 34% from 2024 to 2032, driven by increased penetration rates and the potential implementation of a fee schedule [1][2] Group 1: Market Potential - The overall market size for surgical robots in China is anticipated to grow from 7.2 billion RMB in 2024 to 76.7 billion RMB by 2032, reflecting a CAGR of about 34% [1] - The laparoscopic surgical robot market is expected to see a CAGR of around 29% during the same period, while the orthopedic surgical robot market may achieve a CAGR of approximately 41% [1] Group 2: Catalysts for Growth - The implementation of a fee schedule is identified as a key catalyst for the adoption of domestic surgical robots, with the market expected to enter a rapid development phase by 2026 [2] - The development cycle of domestic surgical robots is categorized into three phases: early development, rapid growth, and maturity, with the rapid growth phase expected to be triggered by improved product capabilities and clear reimbursement policies [2] Group 3: International Expansion - The overseas market for surgical robots is seen as a significant growth opportunity, with China's market currently representing only about 5% of the global market [3] - Several domestic companies, such as MicroPort and Precision Medical, are beginning to penetrate international markets, leveraging product advantages and innovations like 5G remote surgery [3] Group 4: Business Models - The business model of leading companies like Intuitive Surgical demonstrates a clear revenue generation strategy through a combination of systems, consumables, and services, with consumables and services accounting for 76% of revenue by 2024 [4][5] - The domestic laparoscopic surgical robot market is expected to follow a similar model, where device installations drive the growth of consumables and services [5] Group 5: Recommended Companies - Companies with strong commercialization capabilities and innovative production capacities are favored, including MicroPort, Meihua Medical, and Aikang Medical, with additional attention on Tianzhihang and Precision Medical [7]